The demand for cardiac and diabetic medicines is growing rapidly in India. With rising lifestyle disorders, healthcare professionals and patients rely heavily on safe, effective, and affordable drug formulations. This growing demand has opened excellent opportunities in the WHO-GMP Certified PCD Pharma Franchise sector, especially for cardio-diabetic products such as Metformin, Amlodipine, and Telmisartan.
Pharma companies following WHO-GMP (World Health Organization – Good Manufacturing Practices) ensure quality, safety, and efficacy at every stage of production. This is why distributors, wholesalers, and medical representatives prefer partnering with companies offering a WHO-GMP certified PCD Pharma Franchise.
In this blog, we will explore why cardio-diabetic products are the best investment today and highlight some of the top-selling formulations like Metformin-based combinations and DPP4 inhibitors. We will also introduce premium products such as Vildagliptin + Metformin, Teneligliptin + Metformin, and market-leading brands manufactured under stringent WHO-GMP guidelines.
Why Choose a WHO-GMP Certified PCD Pharma Franchise?
A WHO-GMP certification guarantees that every product manufactured meets global health and safety standards. This is especially critical in sensitive segments like cardiac and diabetic care, where dosage accuracy and formulation quality can directly impact patient outcomes.
Benefits of a WHO-GMP Certified Pharma Franchise
-
✔ Guaranteed product safety and consistency
-
✔ Higher doctor trust and prescription rate
-
✔ Expansion into high-growth therapeutic segments
-
✔ Better market acceptance and brand reputation
-
✔ Long-term business stability due to high and consistent product demand
Partnering with a WHO-GMP certified company ensures better profitability, sustainability, and business success in the PCD pharma model.
Growing Demand for Cardiac & Diabetic Medicines in India
India is considered the diabetes capital of the world, with over 100+ million diabetic patients. Cardiovascular diseases also contribute to a large percentage of health complications among adults.
Some of the most prescribed medicines include:
-
Metformin for diabetes management
-
Amlodipine for hypertension
-
Telmisartan for blood pressure control
These medicines have consistent prescription volumes, ensuring steady sales, recurring demand, and higher profits for PCD pharma franchise partners.
Top Cardiac & Diabetic Products for PCD Pharma Franchise
Below are some of the most effective and high-demand products manufactured under WHO-GMP standards. Each product name is clickable and leads to its respective page.
1. GALVED-M
Composition: Vildagliptin 50 mg + Metformin 500 mg
Packing Type: ALU-ALU
Packing Size: 5×2×15
GALVED-M is a powerful DPP4 inhibitor and Metformin combination widely used for type-2 diabetes management. This formulation helps improve glycemic control by increasing insulin secretion and reducing glucose absorption. Its dual-action mechanism makes it highly effective and frequently prescribed.
2. VIDADEN-M
Composition: Vildagliptin 50 mg + Metformin 500 mg
Packing Size: 5×2×15
VIDADEN-M is another high-quality combination of Vildagliptin and Metformin. Recommended for diabetic patients requiring better control over HbA1c levels, this product is well-absorbed and provides excellent results when paired with proper diet and exercise.
3. PAXGLIP-M PLUS
Composition: Teneligliptin 20 mg + Metformin 1000 mg
Packing Type: ALU-ALU
Packing Size: 10×10
This medicine combines Teneligliptin, a highly effective DPP4 inhibitor, with a higher dose of Metformin (1000 mg). It is ideal for patients requiring stronger glucose control. With rapid absorption and high therapeutic value, it is becoming one of the top-selling diabetic products.
4. PAXGLIP-M
Composition: Teneligliptin 20 mg + Metformin 500 mg SR
Packing Type: ALU-ALU
Packing Size: 10×10
PAXGLIP-M provides sustained release (SR) action of Metformin, resulting in better tolerance and long-lasting glucose management. Its dual-action formula enhances insulin secretion and reduces hepatic glucose production, making it a preferred choice among healthcare professionals.
Why Cardio-Diabetic Range is the Best for PCD Pharma Franchise?
✔ High Prescription Rate
Diabetes and hypertension require lifelong treatment, ensuring continuous repeat orders.
✔ Wide Patient Base
Millions of patients depend on medicines like Metformin, Amlodipine, and Telmisartan, ensuring consistent demand.
✔ High Profit Margin
Cardio-diabetic medicines offer better margins compared to general products.
✔ Strong Market Stability
Demand never drops, making it a safe and long-term business investment.
Conclusion
If you want to start or expand your pharma business, partnering with a WHO-GMP Certified PCD Pharma Franchise is the smartest decision. Cardio-diabetic medicines like Metformin, Amlodipine, Telmisartan, and modern DPP4 inhibitors such as Vildagliptin + Metformin and Teneligliptin + Metformin are some of the most profitable segments today.
With high-quality products like GALVED-M, VIDADEN-M, PAXGLIP-M PLUS, and PAXGLIP-M, you can build a strong presence in the market and attract more doctors, chemists, and distributors.